Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian I Rini

Showing results (81-90 of 401) with videos related to

Pageof 41
Sort By:
Urologic Oncology|September 12, 2017
Emerging immunotherapy in advanced renal cell carcinomaPrateek Mendiratta, Brian I Rini, Moshe C Ornstein
The Journal of Urology|May 6, 2004
Practice and progress in kidney cancer: methodology for novel drug developmentBrian I Rini, Vivian Weinberg, Eric J Small
Current Opinion in Oncology|April 9, 2008
Renal cell carcinomaBrian I Rini, W Kimryn Rathmell, Paul Godley
Expert Opinion on Investigational Drugs|May 2, 2008
Axitinib for renal cell carcinomaGuru Sonpavde, Thomas E Hutson, Brian I Rini
Oncotarget|March 28, 2018
Extended therapy breaks from VEGFR TKI therapy in renal cell carcinoma: Sometimes less is moreHaris Zahoor, Brian I Rini, Moshe C Ornstein
JAMA Oncology|November 27, 2018
Emerging Role of Combination Immunotherapy in the First-line Treatment of Advanced Renal Cell Carcinoma: A ReviewSaby George, Brian I Rini, Hans J Hammers
Biologics in Therapy|January 7, 2014
Axitinib in Metastatic Renal Cell CarcinomaKriti Mittal, Laura S Wood, Brian I Rini
Journal for Immunotherapy of Cancer|March 10, 2023
Navigating and adapting care integrating immunotherapy, antiangiogenic therapy, and combinations in patients with advanced renal cell carcinomaBrian I Rini, James Brugarolas, Michael B Atkins
Cancer|December 22, 2004
A phase I trial of fixed dose rate gemcitabine and capecitabine in metastatic renal cell carcinomaBrian I Rini, Vivian Weinberg, Eric J Small
Lancet (London, England)|March 10, 2009
Renal cell carcinomaBrian I Rini, Steven C Campbell, Bernard Escudier
Pageof 41

Showing results (81-90 of 401) with videos related to

Sort By:
Pageof 41
Urologic Oncology|September 12, 2017
Emerging immunotherapy in advanced renal cell carcinomaPrateek Mendiratta, Brian I Rini, Moshe C Ornstein
The Journal of Urology|May 6, 2004
Practice and progress in kidney cancer: methodology for novel drug developmentBrian I Rini, Vivian Weinberg, Eric J Small
Current Opinion in Oncology|April 9, 2008
Renal cell carcinomaBrian I Rini, W Kimryn Rathmell, Paul Godley
Expert Opinion on Investigational Drugs|May 2, 2008
Axitinib for renal cell carcinomaGuru Sonpavde, Thomas E Hutson, Brian I Rini
Oncotarget|March 28, 2018
Extended therapy breaks from VEGFR TKI therapy in renal cell carcinoma: Sometimes less is moreHaris Zahoor, Brian I Rini, Moshe C Ornstein
JAMA Oncology|November 27, 2018
Emerging Role of Combination Immunotherapy in the First-line Treatment of Advanced Renal Cell Carcinoma: A ReviewSaby George, Brian I Rini, Hans J Hammers
Biologics in Therapy|January 7, 2014
Axitinib in Metastatic Renal Cell CarcinomaKriti Mittal, Laura S Wood, Brian I Rini
Journal for Immunotherapy of Cancer|March 10, 2023
Navigating and adapting care integrating immunotherapy, antiangiogenic therapy, and combinations in patients with advanced renal cell carcinomaBrian I Rini, James Brugarolas, Michael B Atkins
Cancer|December 22, 2004
A phase I trial of fixed dose rate gemcitabine and capecitabine in metastatic renal cell carcinomaBrian I Rini, Vivian Weinberg, Eric J Small
Lancet (London, England)|March 10, 2009
Renal cell carcinomaBrian I Rini, Steven C Campbell, Bernard Escudier
Pageof 41